J Korean Ophthalmol Soc.  2004 May;45(5):736-743.

Photodynamic Therapy of Subfoveal Choroidal Neovascularization-Interval and Number of Application of Verteporfin Treatment

Affiliations
  • 1Department of Ophthalmology, Dong-a University, College of Medicine, Dongdaeshin-dong, Seo-gu, Busan, Korea. mediceye@yahoo.co.kr
  • 2Department of Ophthalmology, Yonsei University, College of Medicine, Korea.

Abstract

PURPOSE
To evaluate the interval between, and the total number of, applications of photodynamic therapy in-patients with subfoveal choroidal neovascularization caused by various etiologies. METHODS: Ninety-five patients (108 eyes) received photodynamic therapy. At follow-up examination every 6 weeks, retreatment with the same regimen was applied if angiography showed definite fluorescein leakage. We retrospectively evaluated the interval between treatments and their total number in the group of patients who were able to be followed up for more than 6 months. RESULTS: The average number of applications of verteporfin treatment was 2.46 over a mean follow-up of 14.93 months. The average interval between treatments was 3.65 months. CONCLUSIONS: Further evaluation is needed to analyze the results of photodynamic therapy in Koreans and thereby produce a set of more accurate guidelines.

Keyword

Choroidal neovascularization; Photodynamic therapy; Verteporfin

MeSH Terms

Angiography
Choroid*
Choroidal Neovascularization
Fluorescein
Follow-Up Studies
Humans
Photochemotherapy*
Retreatment
Retrospective Studies
Fluorescein
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr